H1N1 Vaccine in Pregnancy: a Registry for the Fall and Winter of 2009
NCT01374009 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 504
Last updated 2017-01-19
Summary
The goal of this study it to rapidly create a brief registry of pregnant women who receive the H1N1 vaccine in Ontario, British Columbia, and Nova Scotia during the pandemic H1N1 2009/2010 influenza season.
Conditions
- Vaccine Exposure During Pregnancy
Sponsors & Collaborators
-
Li Ka Shing Foundation
collaborator OTHER -
PHAC/CIHR Influenza Research Network
collaborator OTHER_GOV -
Dalhousie University
lead OTHER
Principal Investigators
-
Shelly A McNeil, MD FRCPC · Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS
-
Joel Ray, MD FRCPC · St. Michael's Hospital/University of Toronto, Toronto, Ontario
-
Alison McGeer, MD MSc FRCPC · Mount Sinai Hospital/University of Toronto, Toronto, Ontario
-
Deborah Money, MD FRCSC · University of British Columbia, Vancouver, British Columbia
-
Graeme N Smith, MD PhD FRCSC · Queen's Inversity, Kingston, Ontario
-
Jennifer Blake, MD MSc FRCSC · Sunnybrook Health Sciences Centre and Women's College Hospital, University of Toronto
-
Mark Yudin, MD MSc FRCSC · St. Michael's Hospital, University of Toronto, Toronto, Ontario
-
Muhammad Mamdani, PharmD MPH · Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Ontario
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-04-30
- Primary Completion
- 2010-07-31
- Completion
- 2012-12-31
Countries
- Canada
Study Locations
More Related Trials
-
Brief Influenza Vaccine Education to Pregnant Women
NCT01772901 ·Status: COMPLETED ·Phase: NA
-
Influenza Vaccine Postpartum Questionnaire
NCT00401700 ·Status: COMPLETED
-
Safety of H1N1 Influenza Vaccination in Pregnant Women
NCT01842997 ·Status: COMPLETED ·Phase: PHASE4
-
Influenza Vaccine Safety and Effectiveness in Healthcare Providers
NCT01282177 ·Status: COMPLETED
-
Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months
NCT00996307 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Novartis Pandemic Influenza A (H1N1) Vaccine(s) Observational Comparative Safety Study
NCT01037829 ·Status: COMPLETED
-
Maternal and Fetal Outcomes Following Influenza Vaccination in Pregnancy
NCT04579822 ·Status: UNKNOWN
-
Fluarix/ FluLaval/ Fluarix Quadrivalent/ FluLaval Quadrivalent Vaccine Pregnancy Registry
NCT02148211 ·Status: COMPLETED
-
Rapid Evaluation of Seasonal Influenza Vaccine
NCT00966342 ·Status: WITHDRAWN ·Phase: PHASE1
-
Response to Influenza Vaccine During Pregnancy
NCT03888989 ·Status: TERMINATED ·Phase: PHASE1
-
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
NCT00979602 ·Status: COMPLETED ·Phase: PHASE3
-
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry
NCT02554409 ·Status: COMPLETED
-
Text Message Reminders for Influenza Vaccine in Pregnancy
NCT02428738 ·Status: COMPLETED
-
Afluria Pregnancy Registry
NCT03442582 ·Status: COMPLETED
-
Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults Receiving Seasonal Influenza Vaccine
NCT01000584 ·Status: COMPLETED ·Phase: PHASE4
-
Opting In vs Opting Out
NCT01233804 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of H1N1 Vaccines in Children Aged 6 Months to Less Than 9 Years of Age
NCT00976820 ·Status: COMPLETED ·Phase: PHASE2
-
Surveillance for Adverse Events Following Pandemic H1N1 Immunization
NCT01289418 ·Status: COMPLETED
-
Peds Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels
NCT00944073 ·Status: COMPLETED ·Phase: PHASE2
-
Reverse Genetic H9N2 Influenza Vaccine Study in Adults
NCT01320696 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11
NCT01206114 ·Status: COMPLETED
-
Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Children Aged 6 to 35 Month
NCT01040078 ·Status: UNKNOWN ·Phase: PHASE3
-
H1N1 Vaccine Safety in Manitoba, Canada
NCT01421251 ·Status: UNKNOWN
-
Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Pediatric Populations
NCT02100436 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Age on Response to the 2009 H1N1 Virus Vaccine
NCT01055184 ·Status: COMPLETED ·Phase: PHASE1/PHASE2